Related Experiment Video
Updated: Jul 10, 2026
Efficient Differentiation of Pluripotent Stem Cells to NKX6-1+ Pancreatic Progenitors
Published on: March 7, 2017
Translational embryology: using embryonic principles to generate pancreatic endocrine cells from embryonic stem cells
Jason R Spence1, James M Wells
1Division of Developmental Biology, Cincinnati Children's Hospital Research Foundation, Cincinnati Ohio 45229-3039, USA.
Abstract:
Diseases that affect endodermally derived organs such as the lungs, liver, and pancreas include cystic fibrosis, chronic hepatitis, and diabetes, respectively. Despite the prevalence of these diseases, cures remain elusive. While several promising transplantation-based therapies exist for some diseases such as Type 1 diabetes, they are currently limited by the availability of donor-derived tissues. Embryonic stem cells are a promising and renewable source of tissue for transplantation; however, directing their differentiation into specific, adult cell lineages remains a significant challenge. In this review, we will focus on one endodermally derived organ, the pancreas, and discuss how studies of embryonic pancreas development have been used as the basis for the directed, step-wise differentiation of mouse and human embryonic stem cells into pancreatic endocrine cells that are capable of rescuing Type 1 diabetes in animal models.
Insights
Scientists are using embryonic stem cells to create pancreatic cells for diabetes treatment. This research aims to overcome donor tissue limitations for transplantation therapies, offering a renewable source for Type 1 diabetes.
Area of Science:
- Developmental biology
- Stem cell research
- Endocrinology
Background:
- Diseases affecting endodermally derived organs like the lungs, liver, and pancreas (e.g., cystic fibrosis, hepatitis, diabetes) lack cures.
- Transplantation therapies for diseases like Type 1 diabetes are limited by donor tissue availability.
- Embryonic stem cells offer a renewable tissue source but directed differentiation into specific adult cell lineages is challenging.
Purpose of the Study:
- To review how embryonic pancreas development studies inform directed differentiation of stem cells.
- To explore the step-wise differentiation of mouse and human embryonic stem cells into pancreatic endocrine cells.
- To highlight the potential of these differentiated cells in rescuing Type 1 diabetes in animal models.
Main Methods:
- Review of existing literature on embryonic pancreas development.
- Analysis of protocols for directed, step-wise differentiation of embryonic stem cells.
- Evaluation of studies demonstrating the functional capacity of differentiated cells in vivo.
Main Results:
- Studies of embryonic pancreas development provide a roadmap for directed stem cell differentiation.
- Successful differentiation of mouse and human embryonic stem cells into functional pancreatic endocrine cells has been achieved.
- These differentiated cells show potential in rescuing Type 1 diabetes in preclinical animal models.
Conclusions:
- Embryonic stem cell differentiation holds promise for regenerative medicine in treating endodermally derived organ diseases.
- Understanding developmental biology is crucial for advancing stem cell-based therapies.
- This approach offers a potential solution to donor tissue limitations for pancreatic transplantation.
